Geko Neuromuscular Stimulator vs Thromboembolism Deterrent Stockings (TEDS): DVT Prevention Study
This study is currently recruiting participants.
Verified August 2013 by Firstkind Ltd
Information provided by (Responsible Party):
First received: August 28, 2013
Last updated: August 30, 2013
Last verified: August 2013
This study hypothesises that the geko™ device is more efficient than TEDS in preventing the formation of symptomatic/asymptomatic Deep Vein Thrombosis (DVTs), post-surgery.
Deep Vein Thrombosis
Device: geko™ post-surgery for 48hrs then 4hrs/day until discharge.
Device: TEDS post-surgery for 48hrs then 4hrs/day until discharge.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
|Official Title:||A Multicentre Randomised Controlled Trial Comparing the Incidence of Asymptomatic and Symptomatic Deep Vein Thrombosis Between the gekoTM Device and Thromboembolism Deterrent Stockings in Patients Recovering From Total Hip Replacement Surgery|
Resource links provided by NLM:
Further study details as provided by Firstkind Ltd:
Primary Outcome Measures:
- Presence of asymptomatic DVT assessed by Duplex Ultrasound [ Time Frame: 6 weeks ] [ Designated as safety issue: Yes ]
|Study Start Date:||August 2013|
|Estimated Primary Completion Date:||January 2014 (Final data collection date for primary outcome measure)|
geko™ use continually post-surgery for 48hrs and then a minimum of 4hrs/day until discharge
|Device: geko™ post-surgery for 48hrs then 4hrs/day until discharge.|
Active Comparator: TEDS stockings
TEDS use continually post-surgery for 48hrs and then a minimum of 4hrs/day until discharge
|Device: TEDS post-surgery for 48hrs then 4hrs/day until discharge.|
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01935414
|Contact: Matthew Womack, PhD||+44(0) email@example.com|
|BMI The Harbour Hospital||Recruiting|
|Poole, Dorset, United Kingdom, BH15 2BH|
Sponsors and Collaborators